LPL Financial’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.29M | Buy |
39,942
+210
| +0.5% | +$11.5K | ﹤0.01% | 3610 |
|
|
2026
Q1 | $2.24M | Buy |
39,732
+14,940
| +60% | +$871K | ﹤0.01% | 3393 |
|
|
2025
Q4 | $1.47M | Sell |
24,792
-6,936
| -22% | -$378K | ﹤0.01% | 3683 |
|
|
2025
Q3 | $1.72M | Sell |
31,728
-5,070
| -14% | -$290K | ﹤0.01% | 3459 |
|
|
2025
Q2 | $2.02M | Sell |
36,798
-27,378
| -43% | -$1.61M | ﹤0.01% | 3108 |
|
|
2025
Q1 | $4.54M | Buy |
64,176
+32,903
| +105% | +$2.21M | ﹤0.01% | 2233 |
|
|
2024
Q4 | $2.06M | Sell |
31,273
-1,701
| -5% | -$114K | ﹤0.01% | 2838 |
|
|
2024
Q3 | $2.32M | Buy |
32,974
+1,541
| +5% | +$129K | ﹤0.01% | 2582 |
|
|
2024
Q2 | $2.59M | Sell |
31,433
-1,049
| -3% | -$87.3K | ﹤0.01% | 2381 |
|
|
2024
Q1 | $2.84M | Buy |
32,482
+1,258
| +4% | +$113K | ﹤0.01% | 2232 |
|
|
2023
Q4 | $3.01M | Buy |
31,224
+432
| +1% | +$38.2K | ﹤0.01% | 2076 |
|
|
2023
Q3 | $2.72M | Buy |
30,792
+3,982
| +15% | +$354K | ﹤0.01% | 2050 |
|
|
2023
Q2 | $2.32M | Buy |
26,810
+1,412
| +6% | +$133K | ﹤0.01% | 2114 |
|
|
2023
Q1 | $2.47M | Sell |
25,398
-289
| -1% | -$30K | ﹤0.01% | 1976 |
|
|
2022
Q4 | $2.66M | Sell |
25,687
-859
| -3% | -$80.6K | ﹤0.01% | 1862 |
|
|
2022
Q3 | $2.25M | Sell |
26,546
-3,163
| -11% | -$282K | ﹤0.01% | 1886 |
|
|
2022
Q2 | $2.46M | Sell |
29,709
-2,280
| -7% | -$182K | ﹤0.01% | 1874 |
|
|
2022
Q1 | $2.47M | Sell |
31,989
-34,492
| -52% | -$2.89M | ﹤0.01% | 1892 |
|
|
2021
Q4 | $5.88M | Sell |
66,481
-5,610
| -8% | -$463K | ﹤0.01% | 1356 |
|
|
2021
Q3 | $5.57M | Buy |
72,091
+7,424
| +11% | +$586K | 0.01% | 1327 |
|
|
2021
Q2 | $5.4M | Sell |
64,667
-8,082
| -11% | -$641K | 0.01% | 1292 |
|
|
2021
Q1 | $5.49M | Buy |
72,749
+6,731
| +10% | +$550K | 0.01% | 1166 |
|
|
2020
Q4 | $5.79M | Buy |
66,018
+17,994
| +37% | +$1.43M | 0.01% | 1038 |
|
|
2020
Q3 | $3.65M | Buy |
48,024
+136
| +0.3% | +$13.8K | 0.01% | 1113 |
|
|
2020
Q2 | $5.91M | Buy |
47,888
+4,045
| +9% | +$402K | 0.01% | 796 |
|
|
2020
Q1 | $3.71M | Buy |
43,843
+5,059
| +13% | +$436K | 0.01% | 875 |
|
|
2019
Q4 | $3.28M | Sell |
38,784
-1,322
| -3% | -$99.9K | 0.01% | 1056 |
|
|
2019
Q3 | $2.7M | Sell |
40,106
-2,851
| -7% | -$220K | 0.01% | 1081 |
|
|
2019
Q2 | $3.68M | Buy |
42,957
+8,547
| +25% | +$731K | 0.01% | 918 |
|
|
2019
Q1 | $3.06M | Buy |
34,410
+4,404
| +15% | +$408K | 0.01% | 960 |
|
|
2018
Q4 | $2.56M | Buy |
30,006
+1,263
| +4% | +$120K | 0.01% | 955 |
|
|
2018
Q3 | $2.79M | Sell |
28,743
-781
| -3% | -$78K | 0.01% | 982 |
|
|
2018
Q2 | $2.78M | Buy |
29,524
+19,790
| +203% | +$1.73M | 0.01% | 954 |
|
|
2018
Q1 | $789K | Sell |
9,734
-2,624
| -21% | -$225K | ﹤0.01% | 1785 |
|
|
2017
Q4 | $1.1M | Sell |
12,358
-1,393
| -10% | -$121K | ﹤0.01% | 1455 |
|
|
2017
Q3 | $1.27M | Buy |
13,751
+203
| +1% | +$17.9K | ﹤0.01% | 1270 |
|
|
2017
Q2 | $1.22M | Buy |
13,548
+10,216
| +307% | +$929K | ﹤0.01% | 1248 |
|
|
2017
Q1 | $291K | Buy |
3,332
+750
| +29% | +$66.7K | ﹤0.01% | 2223 |
|
|
2016
Q4 | $218K | Buy |
+2,582
| New | +$222K | ﹤0.01% | 2421 |
|
|
2016
Q2 | – | Sell |
-6,244
| Closed | -$518K | – | 2654 |
|
|
2016
Q1 | $518K | Sell |
6,244
-2,457
| -28% | -$200K | ﹤0.01% | 2134 |
|
|
2015
Q4 | $901K | Buy |
8,701
+2,851
| +49% | +$298K | ﹤0.01% | 1762 |
|
|
2015
Q3 | $641K | Buy |
5,850
+649
| +12% | +$86.7K | ﹤0.01% | 1573 |
|
|
2015
Q2 | $727K | Buy |
5,201
+1,275
| +32% | +$158K | ﹤0.01% | 1598 |
|
|
2015
Q1 | $475K | Buy |
3,926
+1,561
| +66% | +$165K | ﹤0.01% | 1885 |
|
|
2014
Q4 | $214K | Sell |
2,365
-1,438
| -38% | -$120K | ﹤0.01% | 2455 |
|
|
2014
Q3 | $268K | Sell |
3,803
-8,631
| -69% | -$567K | ﹤0.01% | 2259 |
|
|
2014
Q2 | $774K | Sell |
12,434
-3,284
| -21% | -$198K | ﹤0.01% | 1505 |
|
|
2014
Q1 | $1.07M | Buy |
15,718
+3,327
| +27% | +$245K | 0.01% | 1222 |
|
|
2013
Q4 | $872K | Buy |
12,391
+5,438
| +78% | +$369K | 0.01% | 1329 |
|
|
2013
Q3 | $473K | Buy |
+6,953
| New | +$462K | ﹤0.01% | 1695 |
|
Other funds holding BMRN
VPC
LPL Financial's BMRN Position: Q2 2026 in Review
LPL Financial increased its BioMarin Pharmaceuticals (BMRN) stake by 0.53% in Q2 2026, buying an estimated $11.5K and bringing the position to 39,942 shares worth $2.29M. The position accounts for ﹤0.01% of the portfolio, ranked #3610.
LPL Financial first reported a position in BMRN in Q3 2013 and has held it in 50 quarters since. The position peaked at $5.91M in Q2 2020. 565 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.
- LPL Financial held 39,942 shares of BioMarin Pharmaceuticals worth $2.29M as of Q2 2026.
- LPL Financial bought 210 BioMarin Pharmaceuticals shares in Q2 2026, an estimated $11.5K.
- BioMarin Pharmaceuticals made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #3610 holding.
- LPL Financial first reported a position in BioMarin Pharmaceuticals in Q3 2013 and has held it in 50 quarters since.
- LPL Financial's BioMarin Pharmaceuticals position peaked at $5.91M in Q2 2020.
- 565 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.
Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.